文献速递其他结缔组织病

特发性炎症性肌病残疾评估:呼吁线性化

Assessment of disability in idiopathic inflammatory myopathy: a call for linearity.
PubMed 文献 · Rheumatology (Oxford) · 2022-01-01

研究评估学术医学中心残疾评分(ALDS)在特发性炎症性肌病(IIM)患者中的临床计量学特性,采用前瞻性收集的19例接受一线静脉注射免疫球蛋白单药治疗2期研究患者数据,在基线和9周随访时评估ALDS与核心组指标,结果显示ALDS具有良好内部一致性、结构效度和已知组效度,能检测残疾相关变化,但结果需进一步研究。

要点

  • ALDS在IIM患者中显示良好内部一致性(Cronbach's α=0.84)和轻微天花板效应(11%)。
  • ALDS与HAQ-DI呈中至强相关(基线rs=-0.57,随访rs=-0.86)。
  • ALDS变化评分与TIS相关(rs=0.70),可区分TIS≥40的应答者与非应答者(P=0.001)。

核心结论

  • ALDS在肌炎患者中显示出有前景的临床计量学特性,并能检测残疾的相关变化。
  • 这些结果需进一步研究。

研究设计与样本

  • 研究使用前瞻性收集的IIM患者数据,这些患者完成了一项一线静脉注射免疫球蛋白单药治疗的2期研究。
  • 共纳入19例IIM患者,中位年龄59岁,女性12例(63%)。
  • 在基线和9周随访时评估ALDS及肌炎所有核心组指标(包括HAQ-DI),并在9周时评估2016年ACR/EULAR肌炎应答标准中的总改善评分(TIS)。

主要发现

  • 基线时ALDS中位评分为65.4(IQR 58.2-73.5),Cronbach's α=0.84,天花板效应为11%。
  • ALDS与HAQ-DI的相关性为基线rs=-0.57、随访rs=-0.86。
  • ALDS变化评分与TIS相关(rs=0.70),可区分TIS≥40的应答者与非应答者(P=0.001),可区分基于医生临床反应印象的组间差异(P=0.03),并能检测恶化。

关键数值与推荐

  • ALDS为患者报告问卷,包含25个与肌炎残疾相关的条目。
  • TIS≥40用于区分应答者与非应答者,ALDS变化评分在两组间差异有统计学意义(P=0.001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文结论指出这些结果需进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To evaluate the clinimetric properties of the Academic Medical Centre Disability Score (ALDS) in patients with idiopathic inflammatory myopathy (IIM). METHODS: We used prospectively collected data of IIM patients who completed a phase-2 study with first-line IVIG monotherapy. The ALDS is a patient-reported questionnaire which contains 25 items relevant for disability in myositis. ALDS and all core set measures (CSMs) for myositis [including HAQ-Disability Index (HAQ-DI)] were evaluated at baseline and 9 weeks follow-up. In addition, the 2016 ACR/EULAR myositis response criteria outcome called Total Improvement Score (TIS) was evaluated at 9 weeks. We examined floor/ceiling effects, reliability and construct validity of the ALDS. To examine known-group validity, ALDS change scores over time were compared with TIS and physician impression of clinical response. RESULTS: Nineteen patients with IIM [median age 59 years, 12 (63%) female] were enrolled. At baseline, ALDS showed a median score of 65.4 (IQR 58.2-73.5), good Cronbach's alpha (α = 0.84) and a small ceiling effect (11%). Construct validity was confirmed by moderate to strong correlations between ALDS and HAQ-DI [rs = -0.57 (baseline); -0.86 (follow-up)]. ALDS change score correlated with TIS (rs = 0.70), discriminated between responders and non-responders (TIS ≥ 40; P = 0.001), between groups based on physician impression of clinical response (P = 0.03), and detected deterioration. CONCLUSION: The ALDS showed promising clinimetric properties and detected relevant changes in disability in patients with myositis. These results warrant further investigations.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Min M, Walter AW, Lim J, et al. Assessment of disability in idiopathic inflammatory myopathy: a call for linearity. Rheumatology (Oxford). 2022. PMID: 34875011. doi:10.1093/rheumatology/keab906

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。